Navigation Links
MiddleBrook Pharmaceuticals Hires Key Commercial Team Members
Date:11/19/2008

Company prepares to launch Moxatag(TM), the first and only FDA-approved once-daily amoxicillin, in the first quarter of 2009

GERMANTOWN, Md., Nov. 19 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), today announced it has hired the following key commercial team members:

  • Frank L. Koos has joined MiddleBrook Pharmaceuticals as senior vice president, sales & business development. Koos brings nearly 20 years' experience in sales and sales management to his role at MiddleBrook. Prior to joining MiddleBrook, Koos served as vice president of professional sales for Adams Respiratory Therapeutics(R) (Adams). Prior to Adams, Koos held successive leadership roles including vice president of sales for PharMetrics and group director, sales and service at IMS Health. Previously, Koos was a sales representative and a sales trainer for the Ortho Pharmaceutical division of Johnson and Johnson, and he served as a lieutenant in the United States Army.

  • Salvatore A. Buscema has joined MiddleBrook Pharmaceuticals as vice president, sales. Prior to joining MiddleBrook, Buscema held multiple roles of increasing responsibility at Adams where he led two sales force expansions, directed a comprehensive sales force automation project and facilitated trade sales. The Adams field sales teams under Buscema's leadership grew sales from $20 million to over $400 million annually. Buscema began his sales career at IMS Health where his key accounts included Johnson and Johnson and AstraZeneca.

  • Sheila Filipponi has joined MiddleBrook Pharmaceuticals as vice president, trade sales. Filipponi brings over 20 years of sales and sales management experience to MiddleBrook. Prior to joi
    '/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
2. MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
3. MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
4. MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
5. MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
6. MiddleBrook Hires TalenTactics to Recruit National Field Force
7. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
8. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... August 27, 2015 , ... ... recently presented new data on the relationship of genetics and hypertension at the ... on Heart Disease in Vancouver, British Columbia, Canada. The event, which boasts an ...
(Date:8/26/2015)... 26, 2015  The Diabetes Research Institute (DRI), ... Miami Miller School of Medicine, announced today that ... test for the first time a novel transplant ... FDA approved Phase I/II study builds upon decades ... an important first step toward the development of ...
(Date:8/26/2015)... 26, 2015 After litigating and negotiating ... relating to P2i United States patent ... in the United States without any ... of either party. As a result of the parties, settlement, ... California dismissed the case without prejudice. ...
(Date:8/25/2015)... and CARDIFF, UK (PRWEB) , ... August 25, ... ... and accurately determining whether breast tissue lesions are cancerous is described by University ... SPIE, the international society for optics and photonics. , In “ Breast cancer ...
Breaking Biology Technology:Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 2Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 4P2i Settles United States Litigation 2New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 2New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 3New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 4
... 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ... has been completed in the Phase II component of ... paclitaxel/carboplatin for patients with advanced cancers. The principal investigators ... Institute of Cancer Research, London, England, and Dr. Geoff ...
... statistical analysis technique that identifies and removes systematic ... could lead to more precise and reliable measurement ... industrial applications. Known as sequential profile adjustment ... the amount of experimental data required to make ...
... SHANGHAI, July 1 /PRNewswire-Asia/ -- WuXi PharmaTech ... had received an award from BASF for,excellent service and outstanding ... ingredients. , (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ... for a good CRO collaboration partner for years, and,today I ...
Cached Biology Technology:Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carboplatin Head and Neck Cancer Trial 2New statistical technique improves precision of nanotechnology data 2New statistical technique improves precision of nanotechnology data 3New statistical technique improves precision of nanotechnology data 4WuXi PharmaTech Receives Award from BASF 2
(Date:8/24/2015)... MOUNTAIN VIEW, Calif. , Aug. 24, 2015  Based ... & Sullivan recognizes DERMALOG with the 2015 African Biometrics Company ... manufacturer and has achieved substantial commercial success in ... Nigeria , where it has implemented one of ... equipped 23 banks as well as the Central Bank of ...
(Date:8/20/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market and creator of ... Smart Card Alliance and the EMV Migration Forum.  ... Smart Card Alliance Latin America (SCALA) Chapter provides NXT-ID, ... thought leaders promoting adoption of smart card technology. ...
(Date:8/18/2015)... , Aug. 17, 2015 Research and ... of the "Global Biometric Authentication & Identification ... Estimation & Forecast, 2015-2020" report to their ... and identification systems market is expected to grow ... to 2020 and generate over $25 billion (approximately) ...
Breaking Biology News(10 mins):Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 2Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 3Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 4Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 5Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 6NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2
... German . An international team of scientists led ... found the first fossil boreholes of the worm Osedax ... "boneworms" are at least 30 Million years old. This result was ... of the National Academy of Sciences of the USA (PNAS, ...
... learning book, "Touch the Earth," on Monday, April 19, in ... the National Mall organized by the Earth Day Network. This ... last month, with its authors and illustrators on hand to ... multimedia approach to teach middle school students about the Earth,s ...
... Ind. - A new biosensor developed at Purdue ... when communicating with each other, giving researchers a ... or seizure treatments. Marshall Porterfield, an associate ... engineering, postdoctoral researcher Eric McLamore, and graduate student ...
Cached Biology News:Bone-eating worms 30 million years old 2'Touch the Earth' to display at Earth Day on National Mall 2Sensor gives valuable data for neurological diseases and treatments 2Sensor gives valuable data for neurological diseases and treatments 3
... to 48 lanes, 24 bi-directional, of patient ... from either slab gel or capillary sequencers, ... detection parameters in Explorer have been sealed ... We have built Explorer for ease of ...
Molecular Biological Resources offers bulk quantities of existing protein products. Please see the Chimerx divisions website for existing products and contact lloconne@molbiores.com for pricing....
... ISO 9001:2000 Certified USDA Research Registered OLAW ... Training AALAS Certified Technicians ... GLP Documentation Upon Request Focus ... for all your custom immunology service needs. ...
... data collection and automation that is controlled from ... Excel , Pre-configured library of interfaces for ... can be added and configured by the user ... into one spreadsheet , Allows for ...
Biology Products: